MINUTES
Acerca de Minutes
Volver a lo último

CienciaArgenx says efgartigimod met main goal in myositis trial

pendiente de traducción

argenxefgartigimodautoimmune myositis

RReuters★★☆☆☆2026-08-17 08:10Original

Argenx says efgartigimod met main goal in myositis trial
Argenx says efgartigimod met main goal in myositis trialCiencia